ClinicalTrials.Veeva

Menu

The Role of Diaphragmatic Ultrasound as a Predictor of Extubation From Mechanical Ventilation

B

Beni-Suef University

Status

Completed

Conditions

Diaphragm Ultrasound

Treatments

Device: ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT05063526
FMBSUREC/05012020/Ahmed

Details and patient eligibility

About

Aim: To evaluate real-time ultrasound in the evaluation of diaphragmatic thickening, thickening fraction and or excursion to predict extubation outcomes. The investigators aimed to compare these parameters with other traditional weaning measures.

Full description

The diaphragm is an important respiratory muscle and dysfunction is very common in patients receiving mechanical ventilation. Diaphragm fatigue occurs even in patients who successfully pass the Spontaneous Breathing Test (SBT). Interrupting ventilation too early can lead to increased cardiovascular and respiratory pressure (CO2).retention and hypoxemia with up to 25% of patients requiring reinstitution of ventilator support. Unnecessary delays in liberation from mechanical ventilation also can be deleterious. Complications such as ventilator-associated pneumonia and ventilator-induced diaphragm atrophy can be seen with short periods of mechanical ventilation thereby prolonging mechanical ventilation. As SBT monitoring is insensitive to detect early signs of load-capacity imbalance. The evaluation of the diaphragmatic thickening fraction (DTF) may be also helpful to assess diaphragmatic function and its contribution to respiratory workload. Ultrasound can be used to detect the deflection of the diaphragm, which helps to identify patients with diaphragm dysfunction

Enrollment

120 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Critically ill patients intubated for more than 48 hours who are ready for weaning with the following criteria.

    1. positive end-expiratory pressure (PEEP) ≤ 5 cm H2O.
    2. Fraction of inspired oxygen (FiO2) < 0.5.
    3. respiratory rate (RR) < 30 breaths/min.
    4. rapid shallow breathing index < 105, PaO2/FiO2 > 200.
  • Age< 65 years.

Exclusion criteria

  • Age<18 years.
  • Patient with history of plural effusion, trauma to chest and history of mechanical ventilation for < 6 months.
  • patient with neuromuscular diseases affect diaphragm .

Trial design

120 participants in 3 patient groups

Group B
Description:
40 patients who are mechanically ventilated due to pulmonary disease at respiratory ICU had their diagnosis as follows: 21 (53%) had COPD, 8 (20%) had asthma, 5 (13%) had bronchiectasis, 5 (13%) had pneumonia and 1 (3%) had viral influenza H1N1. Out of group B patients, 11 patients (13.75%) had failed weaning, of which 6 patients needed reintubation and 5 patients needed non-invasive positive ventilation of which 3 patients were re-intubated and 2 patients died.
Treatment:
Device: ultrasound
Group A
Description:
40 patients on mechanical ventilation due to non-pulmonary disease at respiratory ICU had their diagnosis as follows: 24 (60%) had congestive heart failure, 4 (10%) had diabetes mellitus, 4 (10%) had sepsis other than pneumonia, 2 (5%) had epilepsy, 2 (5%) had embolic hemiplegia, and 4 (10%) had chronic renal failure. Out of group A patient, 9 patients (11.25%) had failed weaning of which 4 patients needed reintubation and 5 patients needed non-invasive positive ventilation of which 2 patients were reintubated and 3 patients died.
Treatment:
Device: ultrasound
control group.
Description:
40 patients Chronic obstructive pulmonary disease (COPD) from Outpatient Clinic
Treatment:
Device: ultrasound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems